Increased CXCL13 levels that stimulate plasma cell development are consistent with detection of high serum and cervical levels of anti-chlamydial IgG and IgA in women who remain susceptible to repeated chlamydial infection (Darville et al., 2019). The gene discussed is CD79A; the disease is chlamydia trachomatis infectious disease.